Park Sterling Corporation Announces Quarterly Cash Dividend

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
153
Park Sterling Corporation Announces Quarterly Cash Dividend on Common Shares

CHARLOTTE, NC --(Marketwired - January 25, 2017) - Park Sterling Corporation ( NASDAQ : PSTB ), the holding company for Park Sterling Bank, today announced that its board of directors has declared a regular quarterly cash dividend to its common shareholders of $0.04 per common share, payable on February 22, 2017 to all shareholders of record as of the close of business on February 7, 2017. Any future dividends will be subject to board approval.

About Park Sterling Corporation

Park Sterling Corporation, the holding company for Park Sterling Bank, is headquartered in Charlotte, North Carolina. Park Sterling, a regional community-focused financial services company with $3.3 billion in assets, is the largest community bank headquartered in the Charlotte area and has 55 banking offices stretching across the Carolinas and into North Georgia, as well as in Richmond, Virginia. The bank serves professionals, individuals, and small and mid-sized businesses by offering a full array of financial services, including deposit, mortgage banking, cash management, consumer and business finance, capital markets and wealth management services with a commitment to "Answers You Can Bank On℠." Park Sterling prides itself on being large enough to help customers achieve their financial aspirations, yet small enough to care that they do. Park Sterling is focused on building a banking franchise that is noted for sound risk management, strong community focus and exceptional customer service. For more information, visit www.parksterlingbank.com . Park Sterling Corporation shares are traded on NASDAQ under the symbol PSTB.

Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and are subject to a number of factors that could cause actual events to differ materially from those anticipated, including without limitation fluctuations in the market price of the common stock, regulatory, legal and contractual requirements, other uses of capital, the company's financial performance, market conditions generally or modification, extension or termination of the share repurchase authorization by the board of directors. You should not place undue reliance on any forward-looking statement and should consider the above uncertainties as well as the precautionary statements included in Park Sterling's filings with the SEC, including without limitation the "Risk Factors" section of its Form 10-K. Park Sterling undertakes no obligation to update publicly any forward-looking statements.

For additional information contact: Donald K. Truslow Chief Financial Officer (704) 716-2134 don.truslow@parksterlingbank.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 8

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 44

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 46

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 4

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 8

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 4

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 2

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 2

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 5

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 2

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading

Top 5 Most Recently Viewed Articles

Akeso Reports Progress with Ivonescimab in Cancer Treatment

Updated Category News Views 232

Akeso Moves Forward with Promising Cancer Therapy Trials Akeso Biopharma is excited to share fantastic news regarding its latest clinical endeavors in the realm of cancer treatment. The company has successfully enrolled the first patient in the AK112-309 trial, a pivotal Phase III study designed to evaluate the efficacy of ivonescimab in combination with another regimen...

Continue Reading
Quanex Building Products Raises Dividend for Shareholders

Updated Category News Views 168

Quanex Building Products Announces Quarterly Dividend HOUSTON — Quanex Building Products Corporation (NX) is pleased to announce that its Board of Directors declared a quarterly cash dividend of $0.08 per share on its common stock. This dividend is scheduled to be paid to shareholders of record on a specified date, indicating the company's commitment to rewarding its...

Continue Reading
Trump Calls for Transparency from COVID Drug Manufacturers

Updated Category News Views 204

Trump Demands Drug Firms Reveal COVID Vaccine Data Former President Donald Trump has issued a call to pharmaceutical companies to provide concrete evidence regarding the effectiveness of their COVID-19 drugs, particularly emphasizing the need for transparency surrounding their vaccine data. Transparency in Pharmaceuticals On his social media platform, Trump urged these...

Continue Reading
AECOM Technology Sees Stock Surge to Record $108.26 High

Updated Category News Views 106

AECOM Technology Stock Peaks at $108.26 AECOM Technology Corporation has recently achieved a major milestone in the stock market, reaching an impressive high of $108.26. This achievement not only reflects the robust growth of the infrastructure consulting firm but also represents a 43.14% increase in its stock value over the past year. Investors have been showing strong...

Continue Reading
China's Return to US Soybean Purchases Sparks Market Optimism

Updated Category News Views 678

China Resumes U.S. Soybean Purchases Amid Market Changes Recent reports indicate that China has made its initial purchase of U.S. soybeans from the current year’s harvest, marking the end of a prolonged boycott. This significant development comes just ahead of a highly anticipated summit between U.S. President Donald Trump and Chinese President Xi Jinping. Market...

Continue Reading